BAK stock forecast, quote, news & analysis

Key Takeaways

• BAK stock declined -28% over the past 30 days amid weak Q4 2025 earnings, with recurring EBITDA dropping 49% year-over-year to $557 million.
• Over the past quarter, the stock remained flat at 0%, reflecting volatility from early-year lows around $2.90 to mid-March peaks near $4.92 before retreating.
• Key drivers include petrochemical downcycle, Alagoas remediation provisions totaling BRL 18 billion, Bank of America downgrade to Underperform with $2.80 target, and broader sector margin pressures.
• Analyst sentiment shifted negative post-earnings, contributing to heightened selling pressure and elevated trading volumes.
• Macro factors like softening chemical demand and currency fluctuations in Brazil amplified the downturn.

Braskem S.A. (BAK) Company Overview and Market Position

Braskem S.A. is a leading global petrochemical company headquartered in São Paulo, Brazil, specializing in the production of thermoplastic resins such as polyethylene (PE), polypropylene (PP), and polyvinyl chloride (PVC). The company operates integrated petrochemical complexes, converting hydrocarbons into basic chemicals like ethylene and propylene, which feed into downstream resins sold to industries including packaging, automotive, construction, and consumer goods.

Braskem holds a dominant position as the largest producer of thermoplastic resins in the Americas and a top global producer of polypropylene in the United States. Its business model emphasizes vertical integration for operational efficiency, with facilities in Brazil, the U.S., Mexico, and beyond. Exposure to commodity chemical cycles and Brazil's economic conditions, including currency volatility (real vs. USD), directly influences its stock price, as seen in recent margin compression from oversupply and weak demand.

Braskem S.A. (BAK) Stock Price Performance: Last 30 Days vs. Quarter

Over the last 30 days, BAK stock fell sharply -28%, closing at $3.31 on April 6, 2026, from around $4.59 on March 10. The decline was volatile and trend-driven downward, peaking at $4.92 on March 6 before plunging post-earnings on March 27, with accelerated selling on high volume days like March 27 (-10.66%) and April 6 (-8.31%).

For the past quarter, performance was relatively flat at 0%, starting near $3.31 in mid-January, rallying to $4.92 in early March amid sector optimism, then reverting amid negative catalysts. Movement was range-bound between $2.90 and $5.00, with steady volatility tied to news flows rather than a consistent trend.

What Drove BAK Stock Price in the Last 30 Days

The primary catalyst was Braskem's Q4 2025 earnings release on March 26-27, revealing a net loss, recurring EBITDA of $109 million (down sharply), and full-year EBITDA decline of 49% to $557 million due to prolonged petrochemical downcycle, weak spreads, and oversupply. Provisions for Alagoas salt mine remediation (BRL 18 billion total, with BRL 13.9 billion disbursed) weighed on balance sheet perceptions, alongside operating cash consumption of $246 million.

Bank of America downgraded BAK to Underperform from Neutral on March 26, slashing target to $2.80, citing escalating risks and leverage at 14.7x. This triggered post-earnings selloff, with shares dropping over 10% on March 27. Sector sentiment soured on softening global chemical demand and Brazil real weakness, amplifying USD-denominated ADR pressure. High volumes reflected institutional selling amid negative guidance.

What Drove BAK Stock Performance Over the Last Quarter

The quarter's flat trajectory masked intra-period swings, with early gains from January lows ($2.90 on Jan 7) driven by petrochemical recovery hopes and YTD momentum (+12%). A mid-quarter rally to $4.92 reflected broader market trends in materials amid improving spreads, but was reversed by earnings disappointment and downgrade.

Macroeconomic pressures like elevated U.S. interest rates curbing demand, petrochemical oversupply from new capacities, and Brazil's fiscal challenges eroded margins. Institutional behavior shifted cautious post-Q4 results, with leverage concerns prominent. Competitive dynamics in Latin America intensified, but Braskem's scale provided some resilience, though cumulative downcycle effects dominated.

Trending AI Robots

Tickeron’s Trending AI Robots page showcases the platform's top-performing AI trading bots from among hundreds that trade thousands of tickers across various markets. These curated bots represent the most relevant and high-achieving strategies based on recent performance metrics, including win rates, average returns, and risk-adjusted Sharpe ratios. Strategies range from short-term scalping and momentum plays to longer-term trend following and mean reversion, tailored to different timeframes like intraday, swing, or position trading. Users can explore detailed backtests, live results, and bot-specific parameters to find tools aligning with their risk tolerance and portfolio goals. Check out the Trending AI Robots page to discover and deploy these cutting-edge tools today.

BAK Stock Forecast Drivers: What Investors Should Watch Next

Investors should monitor upcoming Q1 2026 earnings around May 12, focusing on EBITDA recovery, Alagoas remediation progress, and guidance amid petrochemical cycle. Industry trends like global resin demand, capacity utilization, and bio-based innovations will shape sentiment.

Macro environment factors include U.S. Federal Reserve rate path, Brazil real stability, inflation in emerging markets, and commodity feedstock costs (naphtha, ethylene). Strategic developments such as potential ADNOC deal rumors or capital structure reviews could act as catalysts or risks.

Key risks involve prolonged downcycle, leverage elevation, regulatory scrutiny on environmental provisions, and analyst updates. Positive catalysts may stem from cost efficiencies or export growth.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full Disclaimers and Limitations.